Ulrike Gnad-Vogt
Director Técnico/Científico/I+D en CureVac SE .
Cargos activos de Ulrike Gnad-Vogt
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
CureVac SE
 CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Director Técnico/Científico/I+D | 01/01/2011 | - |
Historial de carrera de Ulrike Gnad-Vogt
Antiguos cargos conocidos de Ulrike Gnad-Vogt.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CUREVAC N.V. | Director Técnico/Científico/I+D | 01/01/2011 | 01/01/2019 |
| Corporate Officer/Principal | 01/01/2019 | - |
Formación de Ulrike Gnad-Vogt.
| Universität des Saarlandes | Doctorate Degree |
Estadísticas
Internacional
| Alemania | 4 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CUREVAC N.V. | Health Technology |
| Empresas privadas | 1 |
|---|---|
CureVac SE
CureVac SE BiotechnologyHealth Technology CureVac SE engages in the development of tumor immunotherapy. Its pipeline include mRNA-based Cancer Immunotherapies; Protein-based therapies; and mRNA-based Prophylactic Vaccines. The company was founded by Ingmar Hoerr, Florian von der Mülbe, Hans Georg Rammensee, Günther Jung, and Steve Pascolo in 2000 and is headquartered in Tübingen, Germany. | Health Technology |
- Bolsa de valores
- Insiders
- Ulrike Gnad-Vogt
- Experiencia
